The Academy delivers the latest news on biotechnology and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing farther into knowledge and discovery.
By Querida Anderson, Prachi Patel-Predd
Advertisement
Articles by By Querida Anderson, Prachi Patel-Predd
The Clinical Trials reported in this issue include: PHASE I: 1) Cell Genesys and Medarex Remain Positive on Combination Immunotherapy Study 2) Active Biotech Achieves Success with TASQ for Prostate Cancer PHASE II: 1) Myriad Initiates Evaluation of Brain Cancer Drug that Crosses the Blood-Brain Barrier 2) Second Lung Cancer Trial Adds Data to Novel Therapy, and more
Advertisement
Latest Updated Articles
- The Virtual Window: Clinical Trial Reports--April 2007
August 13th 2010
- The Academy: April 2007
August 13th 2010
Advertisement
Advertisement
Trending on OncLive
1
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas
2
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
3
Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026
4
Emiltatug Ledadotin Elicits Responses in Aggressive Adenoid Cystic Carcinoma
5